NEU-0004932

N/A

Report date: 2025/06/11 11:19:50
NME

Base Information

Drug NameNEU-0004932
Drug Alias Nameanti-trypanosomal drugs (GlaxoSmithKline/Northeastern University/Instituto de Parasitologia y Biomedicina Lopez-Neyra/University of St Andrews)NEU-0001200NEU-1200NEU-4438NEU-0004932 +[10] 
ClassificationSmall molecules
Mechanisms of ActionMethionyl-tRNA synthetase inhibitors
TargetsMethionyl-tRNA synthetase
Therapy Area/IndicationsTrypanosomiasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited KingdomSpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesInstituto de Parasitologia y Biomedicina Lopez-NeyraUniversity Of St. AndrewsGlaxosmithkline Plc +[4] 
Inactive CompaniesN/A
Active IndicationsTrypanosomiasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A